Select Page
Pharmacogenomics Predictions for 2018

Pharmacogenomics Predictions for 2018

With the advent in next-generation sequencing and availability of low cost genome sequencers, more information is available in regards to specific variations in genes. 2018 could see a rapid progress in filling the gaps that exist between bringing genomics and drug...
Pharmacogenomics and the Opioid Crisis

Pharmacogenomics and the Opioid Crisis

As I wrote about last month, President Trump has declared a state of emergency regarding the pervasive nature of opioids on the black market, claiming victims of addiction left and right as overdoses, both intentional and accidental, lead to death. Because of its...
Drug Take Backs

Drug Take Backs

President Donald Trump recently declared the opioid epidemic a national state of emergency and has called on tasks forces, law enforcement agencies, and community members to actively participate in the removal of highly-addictive narcotics from the streets. As I’ve...
Statins and Pharmacogenomics

Statins and Pharmacogenomics

For many Americans, statins are a literal life saver. Doctors prescribe statins to patients of theirs with high levels of LDLs, commonly known as the “bad” cholesterol, to prevent cholesterol build-ups from becoming full-blown clogged arteries. By...
Pharmacogenomics, Blood Pressure, and Big Data

Pharmacogenomics, Blood Pressure, and Big Data

It’s 2017, and pharmacists, doctors, and nurses alike still haven’t cracked the code for how to tell which medicines for managing blood pressure work for which patients and why. High blood pressure is an issue that plagues nearly a third of the adult population in the...